CompletedPhase 2

12 Weeks Treatment With 3 Different Doses of BI 10773 in Type 2 Diabetic Patients

NCT00789035

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

1245.9.54001 Boehringer Ingelheim Investigational Site

Capital Federal, Argentina

+73 additional locations

View on ClinicalTrials.gov

Save this trial

Quick facts

Start date: 2008-10
Enrollment: 408 participants
Sponsor: Boehringer Ingelheim
Purpose: treatment

Locations (74)

1245.9.54001 Boehringer Ingelheim Investigational SiteCapital Federal, Argentina
1245.9.54002 Boehringer Ingelheim Investigational SiteCapital Federal, Argentina
1245.9.54007 Boehringer Ingelheim Investigational SiteCapital Federal, Argentina
1245.9.54008 Boehringer Ingelheim Investigational SiteCapital Federal, Argentina
1245.9.54009 Boehringer Ingelheim Investigational SiteCapital Federal, Argentina
1245.9.54010 Boehringer Ingelheim Investigational SiteCapital Federal, Argentina
1245.9.54004 Boehringer Ingelheim Investigational SiteMar del Plata, Argentina
1245.9.54003 Boehringer Ingelheim Investigational SiteMendoza, Argentina
1245.9.54005 Boehringer Ingelheim Investigational SiteSalta, Argentina
1245.9.54006 Boehringer Ingelheim Investigational SiteSalta, Argentina
1245.9.38504 Boehringer Ingelheim Investigational SiteKarlovac, Croatia
1245.9.38503 Boehringer Ingelheim Investigational SiteKrapinske Toplice, Croatia
1245.9.38506 Boehringer Ingelheim Investigational SiteOsijek, Croatia
1245.9.38505 Boehringer Ingelheim Investigational SiteVaraždin, Croatia
1245.9.38501 Boehringer Ingelheim Investigational SiteZagreb, Croatia
1245.9.37201 Boehringer Ingelheim Investigational SiteTallinn, Estonia
1245.9.37202 Boehringer Ingelheim Investigational SiteTallinn, Estonia
1245.9.37203 Boehringer Ingelheim Investigational SiteTallinn, Estonia
1245.9.49007 Boehringer Ingelheim Investigational SiteAschaffenburg, Germany
1245.9.49001 Boehringer Ingelheim Investigational SiteErlangen, Germany
1245.9.49004 Boehringer Ingelheim Investigational SiteHamburg, Germany
1245.9.49005 Boehringer Ingelheim Investigational SiteHamburg, Germany
1245.9.49002 Boehringer Ingelheim Investigational SiteMelsungen, Germany
1245.9.49008 Boehringer Ingelheim Investigational SiteNuremberg, Germany
1245.9.49003 Boehringer Ingelheim Investigational SiteSaint Ingbert/Oberwürzbach, Germany
1245.9.49006 Boehringer Ingelheim Investigational SiteSulzbach-Rosenberg, Germany
1245.9.39006 Boehringer Ingelheim Investigational SiteGenova, Italy
1245.9.39001 Boehringer Ingelheim Investigational SitePisa, Italy
1245.9.39003 Boehringer Ingelheim Investigational SitePisa, Italy
1245.9.39004 Boehringer Ingelheim Investigational SiteSiena, Italy
1245.9.39005 Boehringer Ingelheim Investigational SiteTreviso, Italy
1245.9.37002 Boehringer Ingelheim Investigational SiteKlaipėda, Lithuania
1245.9.37001 Boehringer Ingelheim Investigational SiteVilnius, Lithuania
1245.9.40003 Boehringer Ingelheim Investigational SiteBrasov, Romania
1245.9.40002 Boehringer Ingelheim Investigational SiteBucharest, Romania
1245.9.40004 Boehringer Ingelheim Investigational SiteGalati, Romania
1245.9.40005 Boehringer Ingelheim Investigational SiteTârgu Mureş, Romania
1245.9.70002 Boehringer Ingelheim Investigational SiteKazan', Russia
1245.9.70003 Boehringer Ingelheim Investigational SiteNizhny Novgorod, Russia
1245.9.70004 Boehringer Ingelheim Investigational SitePetrozavodsk, Russia
1245.9.70005 Boehringer Ingelheim Investigational SiteSmolensk, Russia
1245.9.70006 Boehringer Ingelheim Investigational SiteYaroslavl, Russia
1245.9.70007 Boehringer Ingelheim Investigational SiteYaroslavl, Russia
1245.9.70001 Boehringer Ingelheim Investigational SiteYekaterinburg, Russia
1245.9.62002 Boehringer Ingelheim Investigational SiteBratislava, Slovakia
1245.9.62003 Boehringer Ingelheim Investigational SiteLučenec, Slovakia
1245.9.62004 Boehringer Ingelheim Investigational SiteNové Mesto nad Váhom, Slovakia
1245.9.62001 Boehringer Ingelheim Investigational SitePrievidza, Slovakia
1245.9.82006 Boehringer Ingelheim Investigational SiteGoyang, South Korea
1245.9.82008 Boehringer Ingelheim Investigational SiteGoyang, South Korea
1245.9.82007 Boehringer Ingelheim Investigational SiteIncheon, South Korea
1245.9.82002 Boehringer Ingelheim Investigational SitePucheon, South Korea
1245.9.82001 Boehringer Ingelheim Investigational SiteSeoul, South Korea
1245.9.82004 Boehringer Ingelheim Investigational SiteSeoul, South Korea
1245.9.82005 Boehringer Ingelheim Investigational SiteSeoul, South Korea
1245.9.82009 Boehringer Ingelheim Investigational SiteSuwon, South Korea
1245.9.82003 Boehringer Ingelheim Investigational SiteUijeongbu-si, South Korea
1245.9.46003 Boehringer Ingelheim Investigational SiteGothenburg, Sweden
1245.9.46004 Boehringer Ingelheim Investigational SiteHärnösand, Sweden
1245.9.46005 Boehringer Ingelheim Investigational SiteLund, Sweden
1245.9.46001 Boehringer Ingelheim Investigational SiteStockholm, Sweden
1245.9.46002 Boehringer Ingelheim Investigational SiteVästerås, Sweden
1245.9.88605 Boehringer Ingelheim Investigational SiteChanghua, Taiwan
1245.9.88607 Boehringer Ingelheim Investigational SiteKaohsiung City, Taiwan
1245.9.88604 Boehringer Ingelheim Investigational SiteTaichung, Taiwan
1245.9.88606 Boehringer Ingelheim Investigational SiteTainan, Taiwan
1245.9.88601 Boehringer Ingelheim Investigational SiteTaipei, Taiwan
1245.9.88603 Boehringer Ingelheim Investigational SiteTaipei, Taiwan
1245.9.88602 Boehringer Ingelheim Investigational SiteTaoyuan, Taiwan
1245.9.38003 Boehringer Ingelheim Investigational SiteKharkiv, Ukraine
1245.9.38004 Boehringer Ingelheim Investigational SiteKiev, Ukraine
1245.9.38002 Boehringer Ingelheim Investigational SiteOdesa, Ukraine
1245.9.38001 Boehringer Ingelheim Investigational SiteVinnytsia, Ukraine
1245.9.38005 Boehringer Ingelheim Investigational SiteVinnytsia, Ukraine